Coya Therapeutics (COYA) Competitors $6.05 -0.11 (-1.79%) Closing price 07/15/2025 03:59 PM EasternExtended Trading$6.21 +0.16 (+2.71%) As of 07/15/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock COYA vs. TECX, SLDB, ITOS, ETON, ALT, CMPX, CYRX, RVNC, VIGL, and CTORShould you be buying Coya Therapeutics stock or one of its competitors? The main competitors of Coya Therapeutics include Tectonic Therapeutic (TECX), Solid Biosciences (SLDB), iTeos Therapeutics (ITOS), Eton Pharmaceuticals (ETON), Altimmune (ALT), Compass Therapeutics (CMPX), CryoPort (CYRX), Revance Therapeutics (RVNC), Vigil Neuroscience (VIGL), and Citius Oncology (CTOR). These companies are all part of the "pharmaceutical products" industry. Coya Therapeutics vs. Its Competitors Tectonic Therapeutic Solid Biosciences iTeos Therapeutics Eton Pharmaceuticals Altimmune Compass Therapeutics CryoPort Revance Therapeutics Vigil Neuroscience Citius Oncology Tectonic Therapeutic (NASDAQ:TECX) and Coya Therapeutics (NASDAQ:COYA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings. Which has more risk & volatility, TECX or COYA? Tectonic Therapeutic has a beta of 3.17, meaning that its share price is 217% more volatile than the S&P 500. Comparatively, Coya Therapeutics has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500. Which has stronger valuation and earnings, TECX or COYA? Coya Therapeutics has higher revenue and earnings than Tectonic Therapeutic. Coya Therapeutics is trading at a lower price-to-earnings ratio than Tectonic Therapeutic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTectonic TherapeuticN/AN/A-$57.98M-$7.31-2.93Coya Therapeutics$3.55M28.51-$14.88M-$1.07-5.65 Does the media prefer TECX or COYA? In the previous week, Coya Therapeutics had 4 more articles in the media than Tectonic Therapeutic. MarketBeat recorded 5 mentions for Coya Therapeutics and 1 mentions for Tectonic Therapeutic. Tectonic Therapeutic's average media sentiment score of 1.87 beat Coya Therapeutics' score of 0.58 indicating that Tectonic Therapeutic is being referred to more favorably in the media. Company Overall Sentiment Tectonic Therapeutic Very Positive Coya Therapeutics Positive Do analysts rate TECX or COYA? Tectonic Therapeutic currently has a consensus price target of $83.60, suggesting a potential upside of 289.93%. Coya Therapeutics has a consensus price target of $16.50, suggesting a potential upside of 172.73%. Given Tectonic Therapeutic's stronger consensus rating and higher possible upside, research analysts clearly believe Tectonic Therapeutic is more favorable than Coya Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tectonic Therapeutic 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 3.33Coya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TECX or COYA more profitable? Tectonic Therapeutic's return on equity of -30.13% beat Coya Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tectonic TherapeuticN/A -30.13% -27.52% Coya Therapeutics N/A -48.88%-43.32% Do insiders and institutionals have more ownership in TECX or COYA? 62.6% of Tectonic Therapeutic shares are held by institutional investors. Comparatively, 39.8% of Coya Therapeutics shares are held by institutional investors. 9.2% of Tectonic Therapeutic shares are held by company insiders. Comparatively, 12.0% of Coya Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryTectonic Therapeutic beats Coya Therapeutics on 9 of the 14 factors compared between the two stocks. Get Coya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding COYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COYA vs. The Competition Export to ExcelMetricCoya TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$103.03M$2.96B$5.61B$9.29BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-5.6520.2228.5419.58Price / Sales28.51299.17429.2495.01Price / CashN/A43.1536.0257.93Price / Book2.557.568.145.54Net Income-$14.88M-$55.11M$3.24B$257.73M7 Day Performance-2.73%3.81%0.18%-0.08%1 Month Performance11.01%11.60%5.96%8.09%1 Year Performance-21.12%-2.11%26.24%13.02% Coya Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COYACoya Therapeutics1.9444 of 5 stars$6.05-1.8%$16.50+172.7%-21.4%$103.03M$3.55M-5.656TECXTectonic Therapeutic2.4872 of 5 stars$20.78-2.6%$83.60+302.3%+28.8%$398.47MN/A-2.84120Positive NewsSLDBSolid Biosciences3.4406 of 5 stars$4.91-2.4%$15.10+207.5%-37.0%$389.90M$8.09M-1.64100Analyst RevisionITOSiTeos Therapeutics3.301 of 5 stars$10.07-1.1%$15.86+57.5%-37.9%$389.63M$35M-3.3190ETONEton Pharmaceuticals2.0994 of 5 stars$14.39-0.4%$29.67+106.2%+332.0%$387.51M$39.01M-79.9420ALTAltimmune2.1939 of 5 stars$4.43-6.9%$19.00+328.9%-47.1%$386.07M$20K-3.5250CMPXCompass Therapeutics3.0331 of 5 stars$2.64-5.0%$12.67+379.8%+195.0%$384.43M$850K-6.4420Positive NewsCYRXCryoPort2.16 of 5 stars$7.29-4.8%$10.88+49.2%-1.3%$384.05M$228.38M-3.121,186Gap DownRVNCRevance Therapeutics2.6161 of 5 stars$3.65flat$8.45+131.5%N/A$381.02M$234.04M-1.89500VIGLVigil Neuroscience3.7102 of 5 stars$7.99flat$10.80+35.2%+91.9%$381.02MN/A-3.9040CTORCitius Oncology1.6584 of 5 stars$4.71-11.0%$3.00-36.3%N/A$378.51MN/A0.00N/ANews CoverageGap Up Related Companies and Tools Related Companies Tectonic Therapeutic Competitors Solid Biosciences Competitors iTeos Therapeutics Competitors Eton Pharmaceuticals Competitors Altimmune Competitors Compass Therapeutics Competitors CryoPort Competitors Revance Therapeutics Competitors Vigil Neuroscience Competitors Citius Oncology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COYA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COYA Stock Alerts